RD-Biotech Competitors and Similar CompaniesClear all

RD-Biotech's competitors and similar companies include Omega Therapeutics, AnGes, Mustang Bio and Rocket Pharmaceuticals.

	RD-Biotech RD-Biotech is a biotechnology company that offers customized solutions in genomics, immunology, and cell engineering.	Omega Therapeutics Omega Therapeutics is an epigenomic medicine company.	AnGes AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine.	Mustang Bio Mustang Bio is a clinical-stage biopharmaceutical company that specializes in the development of cell and gene therapies.	Rocket Pharmaceuticals Rocket Pharmaceuticals is a biotechnology company focused on seeking cures through molecular and gene therapy.
Founding Date	Founding Date 2002	Founding Date 2017	Founding Date 1999	Founding Date 2015	Founding Date 2018
Type	Type Private	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma
Locations	Locations Besançon, FR HQ Saint Genis Laval, FR	Locations Cambridge, US HQ	Locations Ibaraki, JP HQ Fujisawa, JP Ibaraki, JP Kawasaki, JP Minato City, JP Bethesda, US	Locations Worcester, US HQ	Locations East Windsor, US HQ New York, US
Employees	Employees 613% increase	Employees 60	Employees 5562% decrease	Employees 693% decrease	Employees 5716% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 68.4 m	Valuation ($) 78.3 m	Valuation ($) 11.2 m	Valuation ($) 1.6 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $3.1m (FY, 2023)	Revenue (est.) ¥874.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥499.9m (FY, 2025)	Cost of goods N/A	Cost of goods $1.1m (FY, 2025)
Net income	Net income N/A	Net income ($97.4m) (FY, 2023)	Net income (¥5.1b) (FY, 2025)	Net income ($1.9m) (FY, 2025)	Net income ($223.1m) (FY, 2025)